Dissecting the Contributions of Cooperating Gene Mutations to Cancer Phenotypes and Drug Responses with Patient-Derived iPSCs

Connecting specific cancer genotypes with phenotypes and drug responses constitutes the central premise of precision oncology but is hindered by the genetic complexity and heterogeneity of primary cancer cells. Here, we use patient-derived induced pluripotent stem cells (iPSCs) and CRISPR/Cas9 genom...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Reports
Autors principals: Chang, Chan-Jung, Kotini, Andriana G., Olszewska, Malgorzata, Georgomanoli, Maria, Teruya-Feldstein, Julie, Sperber, Henrik, Sanchez, Roberto, DeVita, Robert, Martins, Timothy J., Abdel-Wahab, Omar, Bradley, Robert K., Papapetrou, Eirini P.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995368/
https://ncbi.nlm.nih.gov/pubmed/29681544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stemcr.2018.03.020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars